We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The World Health Organization reports continuing transmission of Ebola in Uganda. As of 18 November 2022, there have been 141 confirmed cases, including 55 deaths.
Cases have been reported from Mubende, Kampala, Kassanda, Wakiso, Bunyangabu, Kagadi, Kyegegwa, Masaka and Jinja Districts.
Due to increasing case numbers originating in Mubende District, the UK Foreign, Commonwealth and Development Office (FCDO) continues to advise against all but essential travel to Mubende District, Central Uganda.
Ebola virus disease (EVD) is a type of viral haemorrhagic fever (VHF). It is spread through contact with the blood, body fluids or organs of a person or animal with the infection.
Currently, there is no licensed vaccine available for UK travellers to prevent EVD.
The risk to travellers becoming infected or developing EVD is extremely low.
Prior to travelling to Uganda, all travellers should be advised to consider the following measures:
The risk to travellers becoming infected or developing EVD is extremely low. The risk may be higher for medical personnel travelling to work in an outbreak region.
All travellers can minimise their risk of becoming infected or developing EVD by:
In addition, travellers to Uganda should be reminded of general preventative travel health measures to avoid becoming unwell, including:
Travellers should be made aware what they need to do if they develop a fever, with or without additional symptoms (such as headache, myalgia, weakness, abdominal pain, sore throat, vomiting, diarrhoea, unexplained bleeding / bruising), and have:
In this instance, travellers should seek rapid medical attention by calling NHS 24 (Scotland) or NHS 111 (rest of UK), or contacting their GP practice by telephone for advice.
Although it is very unlikely the traveller will have EVD, they should be advised to mention:
For further information, see the TRAVAX Viral Haemorrhagic Fever page.